Home/Filings/4/0001127602-10-031328
4//SEC Filing

SCHNEIER CRAIG ERIC 4

Accession 0001127602-10-031328

CIK 0000875045other

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 3:32 PM ET

Size

9.7 KB

Accession

0001127602-10-031328

Insider Transaction Report

Form 4
Period: 2010-12-17
SCHNEIER CRAIG ERIC
EVP, HR, Public Affairs & Comm
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2010-12-1719,4509,725 total
    Exercise: $49.31Exp: 2017-02-11Common Stock (19,450 underlying)
  • Exercise/Conversion

    Common Stock

    2010-12-17$49.31/sh+19,450$959,08040,566.279 total
  • Sale

    Common Stock

    2010-12-17$68.20/sh19,450$1,326,49021,116.279 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    460
Footnotes (3)
  • [F1]Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
  • [F2]Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d).
  • [F3]The stock option becomes exercisable in four (4) equal annual installments, commencing one year after the grant date of 02/12/07.

Issuer

BIOGEN IDEC INC.

CIK 0000875045

Entity typeother
IncorporatedMA

Related Parties

1
  • filerCIK 0001226289

Filing Metadata

Form type
4
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 3:32 PM ET
Size
9.7 KB